This is an observational study to assess health-related quality of life in patients with cervical dystonia (dystonie) treated with OnabotulinumtoxinA per routine clinical practice.
Study Type
OBSERVATIONAL
Enrollment
62
OnabotulinumtoxinA injections at doses and frequencies as determined by the physician in accordance with clinical practice.
Clinique Neuro-Rive Sud
Greenfield Park, Quebec, Canada
Hôpital Maisonneuve-Rosemont
Montreal, Quebec, Canada
Chum-Notre-Dame
Montreal, Quebec, Canada
Queen Elizabeth Health Centre: Medical Specialist Clinic
Montreal, Quebec, Canada
Change from Baseline in Cervical Dystonia Impact Profile Questionnaire (CDIP-58) Score
Time frame: Baseline, 96 Weeks
Patient's Global Impression of Change (PGIC) Using a 7-Point Scale
Time frame: Baseline, 96 Weeks
Work Productivity Assessment Using a 10-Item Questionnaire
Time frame: 96 Weeks
Change from Baseline in Hospital Anxiety and Depression Scale (HAD) Score
Time frame: Baseline, 96 Weeks
Reasons for Withdrawal of Treatment
Time frame: 96 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
CHU de Québec, Hôpital de l'Enfant-Jésus
Québec, Quebec, Canada
Centre Medical Le Mesnil
Québec, Quebec, Canada
Polyclinique Medicale des Ponts
Saint Romuald, Quebec, Canada
CHU - Sherbrooke
Sherbrooke, Quebec, Canada